{"transactions":[{"id":727851,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":35711,"kind":"person","name":"Martell Christopher","position":1,"cik":"0001873465","reported_name":"Martell Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-24T20:31:10.000Z","date":"2026-06-23","kind":"grant","planned":false,"acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 23, 2027 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the \"Board\") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting."}],"balance_after":32000,"derivative":{"exercise_price":9.08,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001873465-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873465/000187346526000002/ownership.xml","form_type":"4"}},{"id":1101150,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":35711,"kind":"person","name":"Martell Christopher","position":1,"cik":"0001873465","reported_name":"Martell Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-26T12:30:08.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":111349,"price":4.67,"value":519999.83,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired from the Issuer in a registered direct offering pursuant to the terms of a Securities Purchase Agreement dated as of June 23, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Spouse."}],"balance_after":111349,"source":{"system":"sec-edgar","filing":"0000950170-25-090196","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873465/000095017025090196/ownership.xml","form_type":"4"}},{"id":1106485,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":35711,"kind":"person","name":"Martell Christopher","position":1,"cik":"0001873465","reported_name":"Martell Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-18T12:34:55.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":14240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 17, 2026 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the \"Board\") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting."}],"balance_after":14240,"derivative":{"exercise_price":4.94,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":14240},"source":{"system":"sec-edgar","filing":"0000950170-25-087700","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873465/000095017025087700/ownership.xml","form_type":"4"}},{"id":1468224,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":35711,"kind":"person","name":"Martell Christopher","position":1,"cik":"0001873465","reported_name":"Martell Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-27T12:39:20.000Z","date":"2024-06-26","kind":"grant","planned":false,"acquired":true,"shares":14240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 26, 2025 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the \"Board\") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting."}],"balance_after":14240,"derivative":{"exercise_price":5.71,"expiration_date":"2034-06-26","underlying":"Common Stock","underlying_shares":14240},"source":{"system":"sec-edgar","filing":"0000950170-24-078172","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873465/000095017024078172/ownership.xml","form_type":"4"}},{"id":1842112,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":35711,"kind":"person","name":"Martell Christopher","position":1,"cik":"0001873465","reported_name":"Martell Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-29T13:00:14.000Z","date":"2023-06-28","kind":"grant","planned":false,"acquired":true,"shares":14240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 28, 2024 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the \"Board\") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting."}],"balance_after":14240,"derivative":{"exercise_price":1.22,"expiration_date":"2033-06-28","underlying":"Common Stock","underlying_shares":14240},"source":{"system":"sec-edgar","filing":"0001209191-23-040137","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873465/000120919123040137/doc4.xml","form_type":"4"}},{"id":2008071,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":35711,"kind":"person","name":"Martell Christopher","position":1,"cik":"0001873465","reported_name":"Martell Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-17T23:40:24.000Z","date":"2022-12-09","kind":"purchase","acquired":true,"shares":23950,"price":1.92,"value":45984.0,"ownership":{"direct":false,"nature":"By GTAM1 2012 LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.88 to $1.98. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by GTAM1 2012 LLC, which is wholly owned by a trust for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any."}],"balance_after":152000,"source":{"system":"sec-edgar","filing":"0000899243-23-005523","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1873465/000089924323005523/doc4a.xml","form_type":"4/A","original_submission_date":"2022-12-12"}},{"id":2008070,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":35711,"kind":"person","name":"Martell Christopher","position":1,"cik":"0001873465","reported_name":"Martell Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-17T23:40:24.000Z","date":"2022-12-08","kind":"purchase","acquired":true,"shares":3050,"price":1.68,"value":5124.0,"ownership":{"direct":false,"nature":"By GTAM1 2012 LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.55 to $1.80. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by GTAM1 2012 LLC, which is wholly owned by a trust for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any."}],"balance_after":128050,"source":{"system":"sec-edgar","filing":"0000899243-23-005523","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873465/000089924323005523/doc4a.xml","form_type":"4/A","original_submission_date":"2022-12-12"}},{"id":2089929,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":35711,"kind":"person","name":"Martell Christopher","position":1,"cik":"0001873465","reported_name":"Martell Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-12T21:25:27.000Z","date":"2022-12-09","kind":"purchase","acquired":true,"shares":23950,"price":1.92,"value":45984.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.88 to $1.98. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":152000,"source":{"system":"sec-edgar","filing":"0001209191-22-060693","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1873465/000120919122060693/doc4.xml","form_type":"4"}},{"id":2089928,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":35711,"kind":"person","name":"Martell Christopher","position":1,"cik":"0001873465","reported_name":"Martell Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-12T21:25:27.000Z","date":"2022-12-08","kind":"purchase","acquired":true,"shares":3050,"price":1.68,"value":5124.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.55 to $1.80. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":128050,"source":{"system":"sec-edgar","filing":"0001209191-22-060693","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873465/000120919122060693/doc4.xml","form_type":"4"}},{"id":2136449,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":35711,"kind":"person","name":"Martell Christopher","position":1,"cik":"0001873465","reported_name":"Martell Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-17T20:42:52.000Z","date":"2022-10-13","kind":"grant","acquired":true,"shares":14240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) October 13, 2023 or (ii) the date of the next Annual Meeting of Stockholders of the Company; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors of the Company or otherwise ceases to serve as a Director, unless the Board determines that the circumstances warrant continuation of vesting."}],"balance_after":14240,"derivative":{"exercise_price":2.81,"expiration_date":"2032-10-13","underlying":"Common Stock","underlying_shares":14240},"source":{"system":"sec-edgar","filing":"0001209191-22-053831","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873465/000120919122053831/doc4.xml","form_type":"4"}},{"id":2620218,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":35711,"kind":"person","name":"Martell Christopher","position":1,"cik":"0001873465","reported_name":"Martell Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-08-03T00:12:23.000Z","date":"2021-07-29","kind":"exercise","acquired":false,"shares":696851,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By GTAM1 2012 ADV LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering (\"IPO\") without payment of additional consideration. The Series B Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering (\"IPO\") without payment of additional consideration. The Series B Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering (\"IPO\") without payment of additional consideration. The Series B Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by GTAM1 2012 ADV LLC, for which the Reporting Person serves as manager. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":283514},"source":{"system":"sec-edgar","filing":"0000899243-21-031104","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1873465/000089924321031104/doc4.xml","form_type":"4"}},{"id":2620217,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":35711,"kind":"person","name":"Martell Christopher","position":1,"cik":"0001873465","reported_name":"Martell Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-03T00:12:23.000Z","date":"2021-07-29","kind":"purchase","acquired":true,"shares":125000,"price":8,"value":1000000.0,"ownership":{"direct":false,"nature":"By GTAM1 2012 LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by GTAM1 2012 LLC, which is wholly owned by a trust for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any."}],"balance_after":125000,"source":{"system":"sec-edgar","filing":"0000899243-21-031104","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1873465/000089924321031104/doc4.xml","form_type":"4"}},{"id":2620216,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":35711,"kind":"person","name":"Martell Christopher","position":1,"cik":"0001873465","reported_name":"Martell Christopher","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-03T00:12:23.000Z","date":"2021-07-29","kind":"exercise","acquired":true,"shares":283514,"ownership":{"direct":false,"nature":"By GTAM1 2012 ADV LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering (\"IPO\") without payment of additional consideration. The Series B Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by GTAM1 2012 ADV LLC, for which the Reporting Person serves as manager. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any."}],"balance_after":283514,"source":{"system":"sec-edgar","filing":"0000899243-21-031104","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873465/000089924321031104/doc4.xml","form_type":"4"}}]}